TefferiA., ColganJ.P., SolbergL.A.. Acute porphyrias: diagnosis and management. Mayo Clin Proc1994; 69: 991–5.
6.
YoungJ.W., ConteE.T.. Porphyrias and porphyrins. Int J Dermatol1991; 30: 399–406.
7.
KauppinenR., TimonenK., MustajokiP.. Treatment of the porphyrias. Ann Med1994; 26: 31–38.
8.
PaslinD.A.. The porphyrias. Int J Dermatol1992; 31: 527–39.
9.
MarcusD.L., NadelH., LewG., FreedmanM.L.. Cimetidine suppresses chemically induced experimental hepatic porphyria. Am J Med Sci1990; 300: 214–7.
10.
HorieY., UdagawaM., HirayamaC.. Clinical usefulness of Cimetidine for the treatment of acute intermittent porphyria — a preliminary reportClin Chim Acta1987; 167: 267–71.
11.
MarcusD.L., HalbrechtJ.L., BourqueA.L., LewG., NadelH., FreedmanM.L.. Effect of Cimetidine on δ-aminolevulinic acid synthetase and microsomal haem oxygenase in the liver. Biochem Pharmacol1984; 33: 2005–8.
12.
BaccinoE., Lan CheongL.S.H., BussolletteL., MottierD.. Cimetidine in the treatment of acute intermittent porphyria (letter). JAMA1989; 262: 300.
13.
HorieY., NorimotoM., TajimaF., HiroyukiS., NanbaE., KawasakiH.. Clinical usefulness of Cimetidine treatment for acute relapse in intermittent porphyria. Clin Chim Acta1995; 234: 171–5.
14.
1996 Drug topics red book.Montvale, NJ: Medical Economics Company, Inc., 1996.